Page last updated: 2024-08-16

pirinixic acid and pnu-282987

pirinixic acid has been researched along with pnu-282987 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banni, S; Cadeddu, F; Carta, G; Castelli, MP; De Montis, MG; Ennas, MG; Fadda, P; Fattore, L; Fratta, W; Frau, R; Lecca, S; Luchicchi, A; Madeddu, C; Melis, M; Pistis, M; Scheggi, S; Schilstrom, B	1
Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP	1

Other Studies

2 other study(ies) available for pirinixic acid and pnu-282987

Article	Year
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Apr-03, Volume: 33, Issue:14 Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Newborn; Benzamides; Bridged Bicyclo Compounds; Carbamates; Cholinergic Agents; Dihydro-beta-Erythroidine; Dopaminergic Neurons; Drug Interactions; Enzyme Inhibitors; Ethanolamines; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ligands; Male; Patch-Clamp Techniques; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Swimming; Tyrosine 3-Monooxygenase; Ventral Tegmental Area	2013
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence. Neuropharmacology, 2017, 05-15, Volume: 118 Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine	2017

Article

Year

PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Apr-03, Volume: 33, Issue:14

Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Newborn; Benzamides; Bridged Bicyclo Compounds; Carbamates; Cholinergic Agents; Dihydro-beta-Erythroidine; Dopaminergic Neurons; Drug Interactions; Enzyme Inhibitors; Ethanolamines; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ligands; Male; Patch-Clamp Techniques; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Swimming; Tyrosine 3-Monooxygenase; Ventral Tegmental Area

2013

In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.

Neuropharmacology, 2017, 05-15, Volume: 118

Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine

2017